Lawsuits have been filed by two teams of researchers against one of the largest pharmaceutical companies, Merck & Co., alleging scientific fraud charges based off deceptive promotion of the painkiller Vioxx, fake in-house research practices instead of qualified researchers independent academic testing, and an incomplete and delayed account of information to the Food and Drug Administration of deaths in clinical trials.
Vioxx became a "blockuster" drug in 1999 when it went on the market, racking in sales of $2.3 billion in 2003, then was revoked in 2004 after several studies showed that it increased the risk of heart attacks and strokes.
The Journal of the American Medical Association authors coined the term "guest authorship and ghostwriting" to make it appear that research done by its employees or contractors was done by scientists in medical schools and universities
The researchers gained access to the company's thousands of documents in order to bring forth the lawsuit and constructed two JAMA papers that claim to provide a look at practices widespread in the pharmaceutical industry.
JAMA did not request responses from other major pharmaceutical companies and lawyers for Merck are dismissing the JAMA findings.
Full Article
Related Articles
Merck accused of Scientific Fraud
Vioxx makers stuck in lawsuit
Fraudulent charges made on Merck
Vioxx became a "blockuster" drug in 1999 when it went on the market, racking in sales of $2.3 billion in 2003, then was revoked in 2004 after several studies showed that it increased the risk of heart attacks and strokes.
The Journal of the American Medical Association authors coined the term "guest authorship and ghostwriting" to make it appear that research done by its employees or contractors was done by scientists in medical schools and universities
The researchers gained access to the company's thousands of documents in order to bring forth the lawsuit and constructed two JAMA papers that claim to provide a look at practices widespread in the pharmaceutical industry.
JAMA did not request responses from other major pharmaceutical companies and lawyers for Merck are dismissing the JAMA findings.
Full Article
Related Articles
Merck accused of Scientific Fraud
Vioxx makers stuck in lawsuit
Fraudulent charges made on Merck
No comments:
Post a Comment